Literature DB >> 23743495

The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis.

Fatma Ucar1, Sevilay Sezer, Serpil Erdogan, Sumeyya Akyol, Ferah Armutcu, Omer Akyol.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the most common underlying causes of chronic liver injury. They are associated with a wide spectrum of hepatic disorders including basic steatosis, steatohepatitis, and cirrhosis. The molecular and cellular mechanisms underlying hepatic injury in NAFLD and NASH are still unknown. This review describes the roles of oxidative stress and inflammatory responses in the pathogenesis of NAFLD and its progression to NASH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743495      PMCID: PMC6837573          DOI: 10.1179/1351000213Y.0000000050

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  57 in total

1.  Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

Authors:  M B Kadiiska; B C Gladen; D D Baird; D Germolec; L B Graham; C E Parker; A Nyska; J T Wachsman; B N Ames; S Basu; N Brot; G A Fitzgerald; R A Floyd; M George; J W Heinecke; G E Hatch; K Hensley; J A Lawson; L J Marnett; J D Morrow; D M Murray; J Plastaras; L J Roberts; J Rokach; M K Shigenaga; R S Sohal; J Sun; R R Tice; D H Van Thiel; D Wellner; P B Walter; K B Tomer; R P Mason; J C Barrett
Journal:  Free Radic Biol Med       Date:  2005-03-15       Impact factor: 7.376

2.  Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis.

Authors:  Sema Uysal; Ferah Armutcu; Timucin Aydogan; Kayihan Akin; Mustafa Ikizek; M Ramazan Yigitoglu
Journal:  Clin Biochem       Date:  2011-10-08       Impact factor: 3.281

Review 3.  Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Authors:  D Shyangdan; C Clar; N Ghouri; R Henderson; T Gurung; D Preiss; N Sattar; A Fraser; N Waugh
Journal:  Health Technol Assess       Date:  2011-11       Impact factor: 4.014

Review 4.  Iron overload in nonalcoholic steatohepatitis.

Authors:  Naoki Fujita; Yoshiyuki Takei
Journal:  Adv Clin Chem       Date:  2011       Impact factor: 5.394

Review 5.  Free radicals and antioxidants in the year 2000. A historical look to the future.

Authors:  J M Gutteridge; B Halliwell
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

6.  Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.

Authors:  John Willy Haukeland; Jan Kristian Damås; Zbigniew Konopski; Else Marit Løberg; Terese Haaland; Ingeborg Goverud; Peter A Torjesen; Kåre Birkeland; Kristian Bjøro; Pål Aukrust
Journal:  J Hepatol       Date:  2006-03-20       Impact factor: 25.083

7.  Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis.

Authors:  J Michael Estep; Ancha Baranova; Noreen Hossain; Hazem Elariny; Kathy Ankrah; Arian Afendy; Vikas Chandhoke; Zobair M Younossi
Journal:  Obes Surg       Date:  2009-03-12       Impact factor: 4.129

Review 8.  Reactive oxygen species and peroxisomes: struggling for balance.

Authors:  Nina A Bonekamp; Alfred Völkl; H Dariush Fahimi; Michael Schrader
Journal:  Biofactors       Date:  2009 Jul-Aug       Impact factor: 6.113

9.  Role of hepatic iron in non-alcoholic steatohepatitis.

Authors:  Yoshio Sumida; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  Hepatol Res       Date:  2009-03       Impact factor: 4.288

10.  The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance.

Authors:  Omer Akyol; Hasan Herken; Efkan Uz; Ersin Fadillioğlu; Süheyla Unal; Sadik Söğüt; Hüseyin Ozyurt; Haluk Asuman Savaş
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-06       Impact factor: 5.067

View more
  39 in total

1.  Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.

Authors:  Reilly T Enos; Kandy T Velázquez; Jamie L McClellan; Taryn L Cranford; Michael D Walla; E Angela Murphy
Journal:  Nutr Res       Date:  2015-04-11       Impact factor: 3.315

2.  Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Authors:  Margarita Pizarro; Nancy Solís; Pablo Quintero; Francisco Barrera; Daniel Cabrera; Pamela Rojas-de Santiago; Juan P Arab; Oslando Padilla; Juan C Roa; Han Moshage; Alexander Wree; Eugenia Inzaugarat; Ariel E Feldstein; Carlos E Fardella; Rene Baudrand; Arnoldo Riquelme; Marco Arrese
Journal:  Liver Int       Date:  2015-02-23       Impact factor: 5.828

Review 3.  Catalase and nonalcoholic fatty liver disease.

Authors:  Su-Kyung Shin; Hyun-Woo Cho; Seung-Eun Song; Dae-Kyu Song
Journal:  Pflugers Arch       Date:  2018-08-17       Impact factor: 3.657

4.  Therapeutic Effect of Crocin on the NASH Model by Targeting the Fas Receptor Signaling Pathway.

Authors:  Seyyed Ali Mard; Feryal Savari; Anahita Rezaie; Maryam Khosravi
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

5.  Hepatoprotection of Cinnamomum burmannii ethanolic extract against high-fat and cholesterol diet in Sprague-Dawley rats (Rattus norvegicus).

Authors:  Retno Susilowati; Abdul Malik Setiawan; Afida Fatimatuz Zahroh; Zadani Nabila Ashari; Alifatul Iffiyana; Ricky Hertanto; Muhammad Basyarudin; Isnaeni Hartiningsih; Mahrus Ismail
Journal:  Vet World       Date:  2022-04-15

6.  Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.

Authors:  Mariana Verdelho Machado; Leandi Kruger; Mark L Jewell; Gregory Alexander Michelotti; Thiago de Almeida Pereira; Guanhua Xie; Cynthia A Moylan; Anna Mae Diehl
Journal:  Dig Dis Sci       Date:  2015-09-24       Impact factor: 3.199

Review 7.  Oxidative stress as a crucial factor in liver diseases.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 8.  Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.

Authors:  Hyunmi Kim; Da Som Lee; Tae Hyeon An; Hyun-Ju Park; Won Kon Kim; Kwang-Hee Bae; Kyoung-Jin Oh
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

9.  Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis.

Authors:  Xiaoli Sun; Jason S Seidman; Peng Zhao; Ty D Troutman; Nathanael J Spann; Xuchu Que; Fangli Zhou; Zhongji Liao; Martina Pasillas; Xiaohong Yang; Jason A Magida; Tatiana Kisseleva; David A Brenner; Michael Downes; Ronald M Evans; Alan R Saltiel; Sotirios Tsimikas; Christopher K Glass; Joseph L Witztum
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 31.373

10.  Genetic Polymorphism of Manganese Superoxide Dismutase in Behçet's Disease.

Authors:  Efkan Uz; H Ramazan Yilmaz; Ramazan Yağci; İsmail Akyol; Tuğba Ersoy; Gülten Sungur; Ayşe Yiğit; Sunay Duman; Ömer Akyol
Journal:  Arch Rheumatol       Date:  2015-12-14       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.